IRIS
COSTANZO, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.832
EU - Europa 2.663
AS - Asia 2.438
SA - Sud America 363
AF - Africa 43
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 10
Totale 24.360
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.756
SG - Singapore 1.124
CN - Cina 674
DE - Germania 443
UA - Ucraina 427
BR - Brasile 319
HK - Hong Kong 287
IT - Italia 285
SE - Svezia 274
IE - Irlanda 253
GB - Regno Unito 206
RU - Federazione Russa 204
PL - Polonia 192
FR - Francia 175
FI - Finlandia 95
VN - Vietnam 87
KR - Corea 83
CA - Canada 47
IN - India 34
JP - Giappone 29
BE - Belgio 25
AR - Argentina 19
BD - Bangladesh 18
NL - Olanda 18
ZA - Sudafrica 18
MX - Messico 17
ES - Italia 15
TR - Turchia 15
AT - Austria 12
IL - Israele 12
KG - Kirghizistan 12
AU - Australia 10
UZ - Uzbekistan 10
PK - Pakistan 9
CL - Cile 8
EU - Europa 8
ID - Indonesia 8
CH - Svizzera 7
EC - Ecuador 6
IQ - Iraq 6
TN - Tunisia 5
DZ - Algeria 4
LT - Lituania 4
MA - Marocco 4
MY - Malesia 4
PY - Paraguay 4
RO - Romania 4
AL - Albania 3
CO - Colombia 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
GR - Grecia 3
HN - Honduras 3
IR - Iran 3
KE - Kenya 3
OM - Oman 3
RS - Serbia 3
SA - Arabia Saudita 3
AZ - Azerbaigian 2
EG - Egitto 2
GH - Ghana 2
HR - Croazia 2
JM - Giamaica 2
NO - Norvegia 2
NP - Nepal 2
PE - Perù 2
PH - Filippine 2
PT - Portogallo 2
VC - Saint Vincent e Grenadine 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CY - Cipro 1
CZ - Repubblica Ceca 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
JO - Giordania 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
SC - Seychelles 1
SN - Senegal 1
TH - Thailandia 1
TW - Taiwan 1
UY - Uruguay 1
VE - Venezuela 1
Totale 24.360
Salva come PNG Salva come JPEG
Città #
Woodbridge 4.820
Wilmington 3.885
Houston 3.419
Ann Arbor 895
Fairfield 801
Chandler 635
Singapore 581
Ashburn 537
Seattle 394
Jacksonville 393
Beijing 309
Cambridge 290
Hong Kong 281
Dublin 251
Medford 220
Dearborn 178
Kraków 170
New York 153
The Dalles 112
Santa Clara 110
Lawrence 102
Dallas 95
Los Angeles 92
Zhengzhou 84
Mülheim 67
Boardman 54
Munich 54
Buffalo 52
Milan 50
San Diego 48
São Paulo 44
Menlo Park 43
Rome 43
Council Bluffs 42
Moscow 40
San Mateo 34
Falls Church 31
Shanghai 30
Ho Chi Minh City 29
Brussels 24
Chicago 23
London 23
Redwood City 21
Hanoi 20
Nuremberg 20
Hefei 18
San Jose 18
Brooklyn 17
Montreal 17
Saint Petersburg 17
Columbus 16
Mountain View 16
University Park 15
Toronto 14
Stockholm 13
Tokyo 13
Turin 13
Warsaw 13
Manchester 12
Atlanta 11
Guangzhou 11
Kunming 11
Nanjing 11
Norwalk 11
Auburn Hills 10
Jinan 10
Redondo Beach 10
San Francisco 10
Ankara 9
Belo Horizonte 9
Hangzhou 9
Johannesburg 9
Orem 9
Perugia 9
Poplar 9
Pune 9
Boston 8
Nürnberg 8
Verona 8
Amsterdam 7
Changsha 7
Rio de Janeiro 7
Saint Louis 7
Wuhan 7
Campinas 6
Chennai 6
Detroit 6
Elk Grove Village 6
Phoenix 6
Vienna 6
Chengdu 5
Clearwater 5
Curitiba 5
Denver 5
Dhaka 5
Florence 5
Helsinki 5
Nanchang 5
Osasco 5
Shenyang 5
Totale 20.123
Salva come PNG Salva come JPEG
Nome #
The p53/p63/p73 family of transcription factors: overlapping and distinct functions 520
Adalimumab for the treatment of severe psoriasis and psoriatic arthritis 507
Functionalized gold nanoparticles for topical delivery of methotrexate for the possible treatment of psoriasis 491
The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage 475
Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis 470
Superficial and nodular basal cell carcinomas treated with an immune response modifier: a report of seven patients 465
IL-21 Promotes Skin Recruitment of CD4+ Cells and Drives IFN- -Dependent Epidermal Hyperplasia 460
Induction of gene expression via activator protein-1 in the ascorbate protection against UV-induced damage 451
Ascorbate up-regulates MLH1 (Mut L homologue-1) and p73: Implications for the cellular response to DNA damage 440
Actinic keratosis treated with an immune response modifier: a case report of six patients 439
MEK1 inhibition sensitizes primary acute myelogenous leukemia to arsenic trioxide-induced apoptosis 437
Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics 435
Increased levels of IL-17 in tear fluid of moderate-to-severe psoriatic patients is reduced by adalimumab therapy 429
IL-21 in the pathogenesis and treatment of skin diseases 426
Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic target 424
Efficacy of short-term cyclosporine treatment to control psoriasis-related events during efalizumab therapy 423
Psoriatic arthritis and CARD15 gene polymorphisms: no evidence for association in the Italian population 420
Topical treatment of basal cell carcinoma with tazarotene: a clinicopathological study on a large series of cases 414
Structure, function and regulation of p63 and p73 411
The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage 410
PSORS2 markers are not associated with psoriatic arthritis in the Italian population 400
Herpes simplex virus disrupts NF-kappa B regulation by blocking its recruitment on the I kappa B alpha promoter and directing the factor on viral genes. 396
Characterization of a new cancer-associated mutant of p53 with a missense mutation (K351N) in the tetramerization domain 396
Systemic therapy of primary cutaneous B-cell lymphoma, marginal zone type, with rituximab, a chimeric anti-CD20 monoclonal antibody 389
What happened after the clinical trials: Long-term safety and efficacy of ustekinumab in daily clinical practice 389
Elementi di dermatologia 388
Induction of neuronal differentiation by p73 in a neuroblastoma cell line 387
The tumor suppressor activity of IKK alpha in stratified epithelia is exerted in part via the TGF-beta anti proliferative pathway 387
Pathogenic role of interleukin-21 in psoriasis 386
Zosteriform metastasis of occult bronchogenic carcinoma 372
Evidence of increased apoptosis and reduced proliferation in basal cell carcinomas treated with tazarotene 360
Efficacy and safety of long-term infliximab therapy in moderate to severe psoriasis and psoriatic arthritis 350
Additional complexity in p73: induction by mitogens in lymphoid cells and identification of two new splicing variants  and  348
Two new p73 splice variants, gamma and delta, with different transcriptional activity 347
Zosteriform metastasis of occult bronchogenic carcinoma 347
IL-21, a new player in pathogenesis of psoriasis 337
Psoriasis: from pathogenesis to novel therapeutic approaches 336
Anti-LL37 antibodies are present in psoriatic arthritis (PsA) patients: New biomarkers in PsA 333
Use of biological drugs in patients with psoriasis and psoriatic arthritis in Italy: Results from the PSONG survey 322
High-dose Intravenous Immunoglobulin for Severe Drug Reactions: Efficacy in Toxic Epidermal Necrolysis 320
Effects of topical methotrexate loaded gold nanoparticle in cutaneous inflammatory mouse model 320
Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate to severe plaque-type psoriasis: Results from extension phase of the SUPREME study 241
Treatment of vitiligo with the 308 nm excimer laser 194
A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasias 194
308 nm monochromatic excimer light in the treatment of psoriasis 184
Claudin-1 is a p63 target gene with a crucial role in epithelial development 181
Safety and efficacy study on etanercept in patients with plaque psoriasis 175
Different applications of monochromatic excimer light in skin diseases 171
A feedback regulatory loop between p63 and Dlx3: implications for epidermal differentiation 167
Cross-talks in the p53 family - Delta Np63 is an anti-apoptotci target for Delta Np73 alpha and p53 gain-of-function mutants 166
Treasure or artifact: a decade of p63 research speaks for itself 164
p63 and p73 transactivate differentiation gene promoters in human keratinocytes 162
Efficacy of efalizumab in psoriasis patients previously treated with tumour necrosis factor blockers 161
Detection of adalimumab and anti-adalimumab levels by ELISA: clinical considerations 159
The impact of methodological approaches for presenting long-term clinical data on estimates of efficacy in psoriasis illustrated by three-year treatment data on infliximab 157
Efficacy of monochromatic excimer laser radiation (308 nm) in the treatment of early stage mycosis fungoides 156
A role of p73 in mitotic exit 155
p63 induces key target genes required for epidermal morphogenesis 155
Moderate and severe plaque psoriasis: Cost-of-illness study in Italy 154
Targeting MEK/MAPK signal transduction module potentiates ATO-induced apoptosis in multiple myeloma cells through multiple signaling pathways 151
Long-term treatment of plaque psoriasis with efalizumab: an Italian experience 146
Consecutive use of different biological therapies in the treatment of psoriasis [4] 144
Regulation of Dlx5 and Dlx6 gene expression by p63 is involved in EEC and SHFM congenital limb defects 140
Efalizumab 140
Homeobox gene Dlx3 is regulated by p63 during ectoderm development: relevance in the pathogenesis of ectodermal dysplasias 138
Trichostatin A up-regulates p73 and induces Bax-dependent apoptosis in cisplatin-resistant ovarian cancer cells 137
DNA damage-dependent acetylation of p73 dictates the selective activation of apoptotic target genes 137
The p73 gene is an anti-tumoral target of the RAR beta/gamma-selective retinoid tazarotene 136
p73 is regulated by phosphorylation at the G2/M transition 135
RelA/NF-kappa B recruitment on the bax gene promoter antagonizes p73-dependent apoptosis in costimulated T cells 133
Treatment with arsenic trioxide (ATO) and MEK1 inhibitor activates the p73-p53AIP1 apoptotic pathway in leukemia cells 132
Safety and efficacy study on etanercept in patients with plaque psoriasis 131
CD28 delivers a unique signal leading to the selective recruitment of RelA and p52 NF-kappa B subunits on IL-8 and Bcl-xL gene promotors 128
NF-κB, IκB Kinase and Interacting Signal Networks in Squamous Cell Carcinomas 128
Pharmacological treatment of androgenetic alopecia.Result of an observational study 128
Differential regulation of E2F1 apoptotic target genes in response to DNA damage 127
CD28 delivers a unique signal leading to the selective recruitment of RelA and p52 NF-kappaB subunits on IL-8 and Bcl-xL gene promoters 126
A p38-dependent pathway regulates DeltaNp63 DNA binding to p53-dependent promoters in UV-induced apoptosis of keratinocytes 126
The p53 family protein p73 provides new insights into cancer chemosensitivity and targeting 125
deltaEF1 repressor controls selectively p53 family members during differentiation 125
Etanercept for the treatment of severe childhood psoriasis [3] 119
Efficacy and safety of etanercept in psoriasis after switching from other treatments: An observational study 115
IL12B (p40) Gene Polymorphisms Contribute to Ustekinumab Response Prediction in Psoriasis 114
Etanercept reverses downregulation of inhibitor of nuclear factor kappa-B kinase subunit alpha (IKKa) in psoriasis 114
Emerging treatments in the management of psoriasis: biological targeting with ustekinumab 113
Delta Np63 Knockdown Mice: A Mouse Model for AEC Syndrome 108
HLA-Cw6 allele confers sensitivity to efalizumab treatment in psoriasis 102
Pharmacogenomics: getting closer to a tailored therapy? 101
Assessment of HLA Cw6 genotype and correlation to ustekinumab response in a large cohort of patients with moderate-to-severe psoriasis 99
Ustekinumab treatment of erythrodermic psoriasis occurring after physical stress: A report of two cases 96
DNp73 alpha protects myogenic cells from apoptosis 95
Long-term ustekinumab treatment for refractory type I pityriasis rubra pilaris 87
Label-free and non-invasive discrimination of HaCaT and melanoma cells in a co-culture model by hyperspectral confocal reflectance microscopy 79
Cw6 but not allele LCE3C_LCE3B deletion confers sensitivity to ustekinumab treatment in psoriasis 76
HLA-C*06 and response to ustekinumab in Caucasian patients with psoriasis: Outcome and long-term follow-up 74
Keratosis punctata palmoplantaris and malignancies: case report 72
Ustekinumab for treatment of plaque psoriasis in a patient with down syndrome 70
Human leucocyte antigen Cw6 predisposes to clinical response to the inlterleukin-12/23 blocker ustekinumab: results of long-term treatment 67
Next generation sequencing technology to explore anti-inflammatory activity of IKKa in psoriasis 65
Efficacy and safety of ustekinumab in the treatment of patients affected by moderate-to-severe psoriasis 64
Totale 24.296
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.263
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.263
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.430 0 0 0 0 0 267 344 264 143 115 222 75
2021/20221.136 34 90 111 62 29 116 43 59 83 121 59 329
2022/20231.513 166 132 83 245 134 312 83 74 149 6 94 35
2023/2024519 73 18 29 19 42 140 21 68 3 5 6 95
2024/20252.028 114 420 214 156 38 151 161 98 171 148 194 163
2025/20261.806 353 229 516 311 283 114 0 0 0 0 0 0
Totale 24.595